Related Experiment Videos
Adenosine and neuroprotection
1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
International Review of Neurobiology
|January 1, 1997
Summary
Adenosine acts as a natural neuroprotective agent, with therapeutic potential for brain conditions. However, long-term drug effects on adenosine receptors may differ from short-term impacts, indicating crucial adaptive changes in the central nervous system.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Adenosine is recognized as an endogenous neuroprotective agent.
- Multiple mechanisms contribute to adenosine's neuroprotective effects.
- The specific mechanisms may vary depending on the type of ischemia.
Purpose of the Study:
- To review the evidence for adenosine's neuroprotective role.
- To explore the therapeutic potential of drugs targeting adenosine.
- To highlight the differing acute and long-term effects of adenosine receptor modulators.
Main Methods:
- Literature review of studies on adenosine and neuroprotection.
- Analysis of research on drugs affecting adenosine receptors.
- Examination of evidence for adaptive changes in the central nervous system.
Main Results:
- Strong evidence supports adenosine's endogenous neuroprotective capacity.
- Drugs modulating adenosine receptors show therapeutic promise.
- Significant differences exist between acute and long-term effects of adenosine receptor agonists and antagonists.
Conclusions:
- Adenosine is a key endogenous neuroprotective agent.
- Therapeutic strategies targeting adenosine require careful consideration of long-term adaptive effects.
- Acute study results may not predict the long-term clinical utility of adenosine-targeting drugs.